Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes

Cited by (446)

Items 201–300 of 446

1. Investigating the Potential Therapeutic Mechanisms of Puerarin in Neurological Diseases
   Payal Chauhan, Karan Wadhwa, Richa Mishra, Saurabh Gupta, Fuzail Ahmad, Mehnaz Kamal, Danish Iqbal, Mohammed Alsaweed, Mohana Vamsi Nuli, Mosleh Mohammad Abomughaid et al. · 2024 · Molecular Neurobiology
2. Inhibition of Early Growth Response 1 in the Hippocampus Alleviates Neuropathology and Improves Cognition in an Alzheimer Model with Plaques and Tangles
   Xike Qin, Yunling Wang, Hemant K. Paudel · 2017 · American Journal Of Pathology
3. Inhibiting α1‐adrenergic receptor signaling pathway ameliorates AD ‐type pathologies and behavioral deficits in APPswe / PS1 mouse model
   Zhongyuan Yu, Xu Yi, Ye‐Ran Wang, Gui‐Hua Zeng, Cheng‐Rong Tan, Yuan Cheng, Pu‐Yang Sun, Zhihao Liu, Yan‐Jiang Wang, Yuhui Liu · 2022 · Journal of Neurochemistry
4. Regulation of SET Gene Expression by NFkB
   Yi Feng, Xiaoyong Li, Weitao Zhou, Dandan Lou, Daochao Huang, Yanhua Li, Yu Kang, Yan Xiang, Tingyu Li, Weihui Zhou et al. · 2016 · Molecular Neurobiology
5. Crosstalk between Alzheimer’s disease and diabetes: a focus on anti-diabetic drugs
   Golnaz Goodarzi, Sadra Samavarchi Tehrani, Saeed Ebrahimi Fana, Hemen Moradi‐Sardareh, Ghodratollah Panahi, Mahmood Maniati, Reza Meshkani · 2023 · Metabolic Brain Disease
6. Upregulation of human PINK1 gene expression by NFκB signalling
   Xiaoling Duan, Jade Tong, Qin Xu, Yili Wu, Fang Cai, Tingyu Li, Weihong Song · 2014 · Molecular Brain
7. Beneficial Effects of the β-Secretase Inhibitor GRL-8234 in 5XFAD Alzheimer’s Transgenic Mice Lessen During Disease Progression
   Latha Devi, Jordan Tang, Masuo Ohno · 2015 · Current Alzheimer Research
8. Pharmacological Treatment of Alzheimer’s Disease: Insights from Drosophila melanogaster
   Xingyi Cheng, Chaochun Song, Yanjiao Du, Uma Gaur, Mingyao Yang · 2020 · International Journal of Molecular Sciences
9. Inhibition of IFITM3 in cerebrovascular endothelium alleviates Alzheimer's‐related phenotypes
   Yijia Feng, Shengya Wang, Danlu Yang, Zheng Wu, Huwei Xia, Qinxin Zhu, Zhipeng Wang, Bolang Hu, Xinyi Jiang, Xuemei Qin et al. · 2025 · Alzheimer s & Dementia
10. Kinase Targets in Cns Drug Discovery
    Hendra Gunosewoyo, Li-Fang Yu, Lenka Munoz, Michael Kassiou · 2017 · Future Medicinal Chemistry
11. Copy Number Variants in miR-138 as a Potential Risk Factor for Early-Onset Alzheimer’s Disease
    Emmanuelle Boscher, Thomas Husson, Olivier Quenez, Annie Laquerrière, Florent Marguet, Kévin Cassinari, David Wallon, Olivier Martinaud, Camille Charbonnier, Gaël Nicolas et al. · 2019 · Journal of Alzheimer s Disease
12. Recruitment, Retainment, and Biomarkers of Response; A Pilot Trial of Lithium in Humans With Mild Cognitive Impairment
    Ashleigh C. Duthie, Lidy van Aalten, C. F. Macdonald, Alison D. McNeilly, Jennifer Elizabeth Gallagher, John Richard Geddes, Simon Lovestone, Calum D. Sutherland · 2019 · Frontiers in Molecular Neuroscience
13. E-pharmacophore-based virtual screening to identify GSK-3β inhibitors
    Pradeep Natarajan, Vani Priyadarshini, Dibyabhaba Pradhan, Manne Munikumar, Sandeep Swargam, Kanipakam Hema, Bhuma Vengamma, Amineni Umamaheswari · 2015 · Journal of Receptors and Signal Transduction
14. BAG-1M co-activates BACE1 transcription through NF-κB and accelerates Aβ production and memory deficit in Alzheimer’s disease mouse model
    Zhemin Shi, Yuheng Hong, Kun Zhang, Jingzhao Wang, Lina Zheng, Zhen Zhang, Zhimei Hu, Xiaohui Han, Yawei Han, Ting Chen et al. · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
15. Spotlight on Coenzyme Q10 in scopolamine-induced Alzheimer’s disease: oxidative stress/PI3K/AKT/GSK 3ß/CREB/BDNF/TrKB
    Sally A. Abuelezz, Nevien Hendawy · 2023 · Journal of Pharmacy and Pharmacology
16. Encapsulated lactiplantibacillus plantarum improves Alzheimer’s symptoms in APP/PS1 mice
    Fangfang Hu, Qian Gao, Caiyun Zheng, Wenhui Zhang, Ziyi Yang, Shihao Wang, Yanni Zhang, Tingli Lu · 2024 · Journal of Nanobiotechnology
17. Ceramides may Play a Central Role in the Pathogenesis of Alzheimer’s Disease: a Review of Evidence and Horizons for Discovery
    Hans O. Kalkman, Lukasz Smigielski · 2025 · Molecular Neurobiology
18. Melatonin protects against methamphetamine-induced Alzheimer's disease-like pathological changes in rat hippocampus
    Pattama Panmak, Chutikorn Nopparat, Kannika Permpoonpattana, Jatuporn Namyen, Piyarat Govitrapong · 2021 · Neurochemistry International
19. Effects of BACE1 Haploinsufficiency on APP Processing and Aβ Concentrations in Male and Female 5XFAD Alzheimer Mice at Different Disease Stages
    L. Devi, Masuo Ohno · 2015 · Neuroscience
20. Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice
    Dongsheng Zhou, Huaxia Liu, Chenli Li, Fangyan Wang, Yaosheng Shi, Lingjiang Liu, Xin Zhao, Aiming Liu, Junfang Zhang, Chuang Wang et al. · 2016 · Metabolic Brain Disease
21. Cleavage of potassium channel Kv2.1 by BACE2 reduces neuronal apoptosis
    Fuchen Liu, Yun Zhang, Zonglai Liang, Qianwen Sun, Heng Liu, Juan Zhao, Jingwen Xu, Jinfan Zheng, Yan Yun, Xiao Yu et al. · 2018 · Molecular Psychiatry
22. The role of anesthesia in peri‑operative neurocognitive disorders: Molecular mechanisms and preventive strategies
    Ran Li, Yun Zhang, Qinxin Zhu, Yili Wu, Weihong Song · 2023 · Fundamental Research
23. Natural compounds from herbs and nutraceuticals as glycogen synthase kinase‐3β inhibitors in Alzheimer's disease treatment
    Zheng Zhao, Ye Yuan, Shuang Li, Xiaofeng Wang, Xue Yang · 2024 · CNS Neuroscience & Therapeutics
24. Identification of Alzheimer’s disease–associated rare coding variants in the ECE2 gene
    Xinxin Liao, Fang Cai, Zhanfang Sun, Yun Zhang, Juelu Wang, Bin Jiao, Jifeng Guo, Jinchen Li, Xixi Liu, Lina Guo et al. · 2020 · JCI Insight
25. The role of CA1 CB1 receptors on lithium-induced spatial memory impairment in rats
    Salar Vaseghi, Babapour, Mohammad Nasehi, M.R. Zarrindast · 2018 · EXCLI journal
26. BACE 2 degradation mediated by the macroautophagy–lysosome pathway
    Xi Liu, Zhe Wang, Yili Wu, Jianping Wang, Weihong Song · 2013 · European Journal of Neuroscience
27. Chronic rapid eye movement sleep deprivation aggravates the pathogenesis of Alzheimer’s disease by decreasing brain O-GlcNAc cycling in mice
    Dong Yeol Kim, Sang-Min Kim, Inn‐Oc Han · 2024 · Journal of Neuroinflammation
28. Betaine suppressed Aβ generation by altering amyloid precursor protein processing
    Xiuping Liu, Xiang Qian, Yue Xie, Yan Qi, Min-feng Peng, Bi-Cui Zhan, Zhengqing Lou · 2014 · Neurological Sciences
29. Selenomethionine Attenuates the Amyloid-β Level by Both Inhibiting Amyloid-β Production and Modulating Autophagy in Neuron-2a/AβPPswe Cells
    Zhong-Hao Zhang, Qiuyan Wu, Chen Chen, Rui Zheng, Yao Chen, Qiong Liu, Jiazuan Ni, Guo-Li Song · 2017 · Journal of Alzheimer s Disease
30. Traumatic Brain Injury Alters the Metabolism and Facilitates Alzheimer’s Disease in a Murine Model
    Dandan Lou, Yao Du, Daochao Huang, Fang Cai, Yun Liang Zhang, Tin-yu Li, Weihui Zhou, Hongchang Gao, Weihong Song · 2017 · Molecular Neurobiology
31. Elucidation of the GSK3α Structure Informs the Design of Novel, Paralog-Selective Inhibitors
    Amaral, Brenda, Capacci, Andrew, Anderson, Trip, Tezer, Ceren, Bajrami, Bekim, Lulla, Mukesh, Lucas, Brian, Chodaparambil, Jayanth V., Marcotte, Douglas, Kumar, P. Rajesh et al. · 2023 · ACS Chemical Neuroscience
32. Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer’s disease
    Ibtisam Mumtaz, Mir Owais Ayaz, Mohamad Sultan Khan, Umar Manzoor, Mohd Azhardin Ganayee, Aadil Qadir Bhat, Ghulam Hassan Dar, Badrah Saeed Ali Alghamdi, Anwar M. Hashem, Mohd Jamal Dar et al. · 2022 · Frontiers in Aging Neuroscience
33. The synergistic effect of nanocurcumin and donepezil on Alzheimer's via PI3K/AKT/GSK-3β pathway modulating
    Doha Mohammad Beltagy, Nagat Fawzy Nawar, Tarek Mostafa Mohamed, Ehab Tousson, Mai M. El-Keey · 2023 · Prostaglandins & Other Lipid Mediators
34. P2X7 Receptor: an Emerging Target in Alzheimer’s Disease
    Qiang Huang, Jun Ying, Wen Yu, Yao Dong, Hao Xiong, Yiping Zhang, Jie Liu, Xifeng Wang, Fuzhou Hua · 2023 · Molecular Neurobiology
35. Neuro-protection of Chlorogenic acid against Al-induced apoptosis in PC12 cells via modulation of Al metabolism and Akt/GSK-3β pathway
    Dai Cheng, Guangliang Wang, Xuerui Wang, Jinlei Tang, Qianqian Yu, Xinyu Zhang, Shuo Wang · 2020 · Journal of Functional Foods
36. Opportunities for multiscale computational modelling of serotonergic drug effects in Alzheimer's disease
    Alok Joshi, Da‐Hui Wang, Steven Watterson, Paula L. McClean, Chandan Kumar Behera, Trevor Sharp, KongFatt Wong‐Lin · 2020 · Neuropharmacology
37. The Advancements of Marine Natural Products in the Treatment of Alzheimer’s Disease: A Study Based on Cell and Animal Experiments
    Chunbo Jia, Jiaxin Chai, Shenyun Zhang, Yining Sun, Liheng He, Zhipei Sang, Dapeng Chen, Xu Zheng · 2025 · Marine Drugs
38. A cellular model of amyloid precursor protein processing and amyloid-β peptide production
    MiMi P. Macias, Amanda M. Gonzales, Ashley L. Siniard, Aaron W. Walker, Jason J. Corneveaux, Matthew J. Huentelman, Marwan Noel Sabbagh, Boris Decourt · 2013 · Journal of Neuroscience Methods
39. Therapeutic implications of glycogen synthase kinase-3β in Alzheimer’s disease: a novel therapeutic target
    Deepa S. Mandlik, Satish K. Mandlik, S. Arulmozhi · 2022 · International Journal of Neuroscience
40. Synthesis and biological evaluation of thieno[3,2-c]pyrazol-3-amine derivatives as potent glycogen synthase kinase 3β inhibitors for Alzheimer’s disease
    Ning Yan, Fei Xie, Long-Qian Tang, Defeng Wang, Xiang Li, Chao Liu, Zhaopeng Liu · 2023 · Bioorganic Chemistry
41. Alpha-lipoic acid alleviates cognitive deficits in transgenic APP23/PS45 mice through a mitophagy-mediated increase in ADAM10 α-secretase cleavage of APP
    Jie Zhang, Yanshuang Jiang, Xiangjun Dong, Zijun Meng, Liangye Ji, Yu Kang, Mingjing Liu, Weihui Zhou, Weihong Song · 2024 · Alzheimer s Research & Therapy
42. Administration of NaHS Attenuates Footshock-Induced Pathologies and Emotional and Cognitive Dysfunction in Triple Transgenic Alzheimer’s Mice
    Hei-Jen Huang, Shu-Ling Chen, Hsiu Mei Hsieh‐Li · 2015 · Frontiers in Behavioral Neuroscience
43. Therapies for Alzheimer’s disease: a metabolic perspective
    Raquel Domingues, Cláudia Pereira, Maria Teresa Cruz, Ana Silva · 2021 · Molecular Genetics and Metabolism
44. Zinc in Regulating Protein Kinases and Phosphatases in Neurodegenerative Diseases
    Hui-Liang Zhang, Xiaochuan Wang, Rong Liu · 2022 · Biomolecules
45. Innovative pathological network‐based multitarget approaches for Alzheimer's disease treatment
    Paloma Mayo, Jorge Pascual-Guerra, Enrique Crisman, Cristina Domínguez, Manuela G. López, Rafael M. Leon · 2024 · Medicinal Research Reviews
46. Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients
    Leda Leme Talib, Sérgio R. Hototian, Helena Passarelli Giroud Joaquim, Orestes Vicente Forlenza, Wagner F. Gattaz · 2015 · European Archives of Psychiatry and Clinical Neuroscience
47. The effects of GSK-3β blockade on ketamine self-administration and relapse to drug-seeking behavior in rats
    Xianni Huang, Kunyu Huang, Wenhui Zheng, Thomas J.R. Beveridge, Shujun Yang, Xingxing Li, Pengping Li, Wenhua Zhou, Yu Liu · 2014 · Drug and Alcohol Dependence
48. Regulation of LRRK2 promoter activity and gene expression by Sp1
    Juelu Wang, Weihong Song · 2016 · Molecular Brain
49. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11 month old APP/PS1 transgenic mice: A Western blot study
    Zhao-Xu Zhang, Ruiping Zhao, Desheng Wang, An-Ning Wang · 2016 · Experimental Gerontology
50. Andrographolide promotes hippocampal neurogenesis and spatial memory in the APPswe/PS1ΔE9 mouse model of Alzheimer’s disease
    Sebastián B. Arredondo, Daniel T. Reyes, Andrea Herrera-Soto, Muriel D. Mardones, Nibaldo C. Inestrosa, Lorena Varela‐Nallar · 2021 · Scientific Reports
51. Elevated β-secretase 1 expression mediates CD4+ T cell dysfunction via PGE2 signalling in Alzheimer’s disease
    Linbin Dai, Qiong Wang, Xinyi Lv, Feng Gao, Zuolong Chen, Yong Shen · 2021 · Brain Behavior and Immunity
52. The Rationale for Insulin Therapy in Alzheimer’s Disease
    Samo Ribarič · 2016 · Molecules
53. Enhanced Gasdermin-E-mediated Pyroptosis in Alzheimer’s Disease
    Qunxian Wang, Shipeng Guo, Dongjie Hu, Xiangjun Dong, Zijun Meng, Yanshuang Jiang, Zijuan Feng, Weihui Zhou, Weihong Song · 2023 · Neuroscience
54. Pharmacological modulation of the PI3K/AKT/GSK3β axis: a new frontier in Alzheimer’s disease treatment
    Saad Misfer Alqahtani, Hayder Mutter Al-Kuraishy, Ali Ismail Al-Gareeb, Ali K. Albuhadily, Mustafa M Shokr, Athanasios T. Alexiou, Marios Papadakis, Gaber El‐Saber Batiha · 2025 · Inflammopharmacology
55. 3×Tg-AD Mice Overexpressing Phospholipid Transfer Protein Improves Cognition Through Decreasing Amyloid-β Production and Tau Hyperphosphorylation
    Wen-Zhi Wang, Mingwei Li, Ying Chen, Liyuan Liu, Yong Xu, Zeng-Hui Xia, Yang Yu, Xiaodan Wang, Wei Chen, Feng Zhang et al. · 2021 · Journal of Alzheimer s Disease
56. Natural products as potential modulators of pro-inflammatory cytokines signalling in Alzheimer's disease
    Vikas Yadav, Chandrasekaran Mythri, Murali Kumarasamy · 2024 · Brain Behavior and Immunity Integrative
57. The Dual Role of Kinin/Kinin Receptors System in Alzheimer’s Disease
    Bingyuan Ji, Qinqin Wang, Qingjie Xue, Wenfu Li, Xuezhi Li, Yili Wu · 2019 · Frontiers in Molecular Neuroscience
58. Phosphorylation of FE65 at threonine 579 by GSK3β stimulates amyloid precursor protein processing
    Yat Shing Lee, Wan Ning Vanessa Chow, Kwok‐Fai Lau · 2017 · Scientific Reports
59. GSK3α: An Important Paralog in Neurodegenerative Disorders and Cancer
    Silva-García, Octavio, Cortés-Vieyra, Ricarda, Mendoza-Ambrosio, Francisco N., Ramírez-Galicia, Guillermo, Baizabal-Aguirre, Víctor M. · 2020 · Biomolecules
60. The Evolution of AChE Inhibitors in Alzheimer's Disease: From Single‐Target to Multi‐Target Ligands
    Namrashee V. Mehta, Akshay Kapadia, Mihir Khambete, Arundhati Nachiket Abhyankar · 2025 · ChemBioChem
61. Neuroprotective Effect of NO-Delivery Dinitrosyl Iron Complexes (DNICs) on Amyloid Pathology in the Alzheimer’s Disease Cell Model
    Wen-Han Chuang, Yu-Ting Chou, Yi-Hong Chen, Ting-Han Kuo, Wen‐Feng Liaw, Tsai‐Te Lu, Chih-Fei Kao, Yun‐Ming Wang · 2023 · ACS Chemical Neuroscience
62. Atlas stumbled: Kinesin light chain‐1 variant E triggers a vicious cycle of axonal transport disruption and amyloid‐β generation in Alzheimer's disease
    Kathlyn J. Gan, Takashi Morihara, Michael A Silverman · 2014 · BioEssays
63. A Novel Alzheimer-Associated SNP in Tmp21 Increases Amyloidogenesis
    Xiaojie Zhang, Yili Wu, Fang Cai, Shengchun Liu, Kelley Bromley‐Brits, Kun Xia, Weihong Song · 2017 · Molecular Neurobiology
64. Experimental approaches for altering the expression of Abeta‐degrading enzymes
    David A. Loeffler · 2023 · Journal of Neurochemistry
65. Exploring Novel GSK-3β Inhibitors for Anti-Neuroinflammatory and Neuroprotective Effects: Synthesis, Crystallography, Computational Analysis, and Biological Evaluation
    Izabella Góral, Tomasz Wichur, Emilia Sługocka, Przemysław Grygier, Monika Głuch‐Lutwin, Barbara Mordyl, Ewelina Honkisz-Orzechowska, Natalia Szałaj, Justyna Godyń, Dawid Panek et al. · 2024 · ACS Chemical Neuroscience
66. Alzheimer’s Disease and Diabetes Mellitus in Comparison: The Therapeutic Efficacy of the Vanadium Compound
    Zhijun He, Guanying You, Qiong Liu, Nan Li · 2021 · International Journal of Molecular Sciences
67. Selenomethionine Ameliorates Neuropathology in the Olfactory Bulb of a Triple Transgenic Mouse Model of Alzheimer’s Disease
    Zhong-Hao Zhang, Chen Chen, Qiuyan Wu, Rui Zheng, Yao Chen, Qiong Liu, Jiazuan Ni, Guo-Li Song · 2016 · International Journal of Molecular Sciences
68. Chronic Mild Stress Modified Epigenetic Mechanisms Leading to Accelerated Senescence and Impaired Cognitive Performance in Mice
    Dolors Puigoriol‐Illamola, Mirna Guadalupe Martínez-Damas, Christian Griñán‐Ferré, Mercè Pallàs · 2020 · International Journal of Molecular Sciences
69. Metabolomics analyses and comparative insight to neuroprotective potential of unripe fruits and leaves of Citrus aurantium ethanolic extracts against cadmium-induced rat brain dysfunction: involvement of oxidative stress and akt-mediated CREB/BDNF and GSK3β/NF-κB signaling pathways
    Doaa Abd Elhady Deabes, Eman A. W. El-Abd, Sara M. Baraka, Zeinab A. El‐Gendy, Reda M. S. Korany, Marwa Mahmoud Elbatanony · 2025 · Metabolic Brain Disease
70. The link between sarcopenic obesity and Alzheimer's disease: a brain‐derived neurotrophic factor point of view
    Emily N. Copeland, Paul J. LeBlanc, Paula Duarte‐Guterman, Val Andrew Fajardo, Rebecca E. K. MacPherson · 2025 · The Journal of Physiology
71. Midbrain degeneration triggers astrocyte reactivity and tau pathology in experimental Alzheimer’s Disease
    Livia La Barbera, Paraskevi Krashia, Gilda Loffredo, Emma Cauzzi, Maria Luisa De Paolis, Martina Montanari, Luana Saba, Elena Spoleti, Serena Ficchì, Claudio Zaccone et al. · 2025 · Molecular Neurodegeneration
72. American Ginseng for the Treatment of Alzheimer’s Disease: A Review
    Mengyao Shan, Yunfan Bai, Xiaoxue Fang, Xintian Lan, Yegang Zhang, Yiming Cao, Difu Zhu, Haoming Luo · 2023 · Molecules
73. Gypenoside IX restores Akt/GSK-3β pathway and alleviates Alzheimer’s disease-like neuropathology and cognitive deficits
    Lei Ling, Yong Luo, Dongkun Kang, Fumin Yang, Dongli Meng, Jian‐Zhi Wang, Rong Liu, Xiaochuan Wang, Honglian Li · 2023 · Aging
74. Unlocking hope: GSK-3 inhibitors and Wnt pathway activation in Alzheimer’s therapy
    Magham Sai Varshini, Ramakkamma Aishwarya Reddy, Praveen Thaggikuppe Krishnamurthy · 2024 · Journal of drug targeting
75. RETRACTED ARTICLE: Roflumilast and tadalafil improve learning and memory deficits in intracerebroventricular Aβ1–42 rat model of Alzheimer’s disease through modulations of hippocampal cAMP/cGMP/BDNF signaling pathway
    Noorul Hasan, Saima Zameer, Abul Kalam Najmi, Suhel Parvez, Mohammad Shahar Yar, Mohd Akhtar · 2021 · Pharmacological Reports · Retracted
76. Transcriptional regulation of human USP 24 gene expression by NF‐kappa B
    Ke Wang, Shengchun Liu, Juelu Wang, Yili Wu, Fang Cai, Weihong Song · 2013 · Journal of Neurochemistry
77. The BACE1-Specific DNA Aptamer A1 Rescues Amyloid-β Pathology and Behavioral Deficits in a Mouse Model of Alzheimer's Disease
    Zhiman Liang, Yonghua Peng, Yue Chen, Li-Li Long, Hong-Jie Luo, Yajun Chen, Yanling Liang, Ying-Hong Tian, Shu-Ji Li, Yusheng Shi et al. · 2019 · Nucleic Acid Therapeutics
78. Association between insulin and Nrf2 signalling pathway in Alzheimer's disease: A molecular landscape
    Syed Obaidur Rahman, Tahira Moeen Khan, Ashif Iqubal, Shivani Agarwal, Mohd Akhtar, Suhel Parvez, Zahoor Ahmad Shah, Abul Kalam Najmi · 2023 · Life Sciences
79. DVL/GSK3/ISL1 pathway signaling: unraveling the mechanism of SIRT3 in neurogenesis and AD therapy
    Nan Dai, Xiaorong Su, Aihua Li, Jinglan Li, Deqi Jiang, Yong Wang · 2024 · Stem Cell Research & Therapy
80. Two novel DNA motifs are essential for BACE1 gene transcription
    Yan Xiang, Shasha Meng, Jinfeng Wang, Songyang Li, Jingru Liu, Hongmei Li, Tingyu Li, Weihong Song, Weihui Zhou · 2014 · Scientific Reports
81. Paradigm shift redefining molecular, metabolic and structural events in Alzheimer’s disease involves a proposed contribution by transition metals. Defined lengthy preclinical stage provides new hope to circumvent advancement of disease- and age-related neurodegeneration
    Franco Cavaleri · 2015 · Medical Hypotheses
82. NeuroTransDB: highly curated and structured transcriptomic metadata for neurodegenerative diseases
    Shweta Bagewadi, Subash Adhikari, Anjani Dhrangadhariya, Afroza Khanam Irin, Christian Ebeling, Aishwarya Alex Namasivayam, Matthew Page, Martin Hofmann‐Apitius, Philipp Senger · 2015 · Database
83. Oxidative Stress and Alzheimer’s Disease
    Yili Wu, Qin Xu, Weihong Song · 2014 · Springer eBooks
84. Tetrahydroalstonine possesses protective potentials on palmitic acid stimulated SK-N-MC cells by suppression of Aβ1-42 and tau through regulation of PI3K/Akt signaling pathway
    Kang Chen, Guran Yu · 2023 · European Journal of Pharmacology
85. Leveraging Artificial Intelligence for Synergies in Drug Discovery: From Computers to Clinics
    Priyanka Arora, Manaswini Behera, Shubhini Awasthi Saraf, Rahul Shukla · 2024 · Current Pharmaceutical Design
86. Pterostilbene Ameliorates Cognitive Impairment in Polycystic Ovary Syndrome Rat Model through Improving Insulin Resistance via the IRS-1/PI3K/Akt/GSK-3β Pathway: A Comparative Study with Metformin
    Aliaa M. Foda, Safinaz S. Ibrahim, Sherehan M. Ibrahim, Eman Maher Elbaz · 2024 · ACS Chemical Neuroscience
87. Regulation of global gene expression in brain by TMP21
    Xiaojie Zhang, Yili Wu, Fang Cai, Weihong Song · 2019 · Molecular Brain
88. Applications of artificial intelligence in drug discovery for neurological diseases
    Sean Ekins, Thomas R. Lane · 2025 · Neurotherapeutics
89. Integrative machine learning and molecular simulation approaches identify GSK3β inhibitors for neurodegenerative disease therapy
    Hassan H. Alhassan · 2025 · Scientific Reports
90. Neuropathological Mechanisms of β-N-Methylamino-L-Alanine (BMAA) with a Focus on Iron Overload and Ferroptosis
    Hamed Kazemi Shariat Panahi, Mona Dehhaghi, Benjamin Heng, Darius J.R. Lane, Ashley Ian Bush, Gilles J. Guillemin, Vanessa X. Tan · 2022 · Neurotoxicity Research
91. BRI2 ectodomain affects Aβ42 fibrillation and tau truncation in human neuroblastoma cells
    M. Del Campo, Catarina Resende Oliveira, Wiep Scheper, Rob Zwart, Carsten Korth, Andreas Müller‐Schiffmann, George Kostallas, Henrik Biverstål, Jenny Presto, Jan Johansson et al. · 2014 · Cellular and Molecular Life Sciences
92. Alzheimer’s disease pathology and the unfolded protein response: prospective pathways and therapeutic targets
    David J. Koss, Bettina Platt · 2017 · Behavioural Pharmacology
93. Synergistic anticancer effects of metformin and Achillea vermicularis Trin-loaded nanofibers on human pancreatic cancer cell line: An in vitro study
    Ravana Babazade, Elif Beyzanur Polat, Büşra Ertaş, Gul Sinemcan Ozcan, Humeysa Kiyak‐Kirmaci, Esra Tatar, Turgut Taşkın, Yusufhan Yazır, Muhammet Emin Çam · 2022 · European Polymer Journal
94. Impact of GSK-3β and CK-1δ on Wnt signaling pathway in alzheimer disease: A dual target approach
    Vinita Sharma, Prabodh Chander Sharma, Jurnal Reang, Vivek Yadav, Rajiv Kumar Tonk, Jaseela Majeed, Kalicharan Sharma · 2024 · Bioorganic Chemistry
95. Connecting GSK-3β Inhibitory Activity with IKK-β or ROCK-1 Inhibition to Target Tau Aggregation and Neuroinflammation in Alzheimer’s Disease—Discovery, In Vitro and In Cellulo Activity of Thiazole-Based Inhibitors
    Izabella Góral, Tomasz Wichur, Emilia Sługocka, Justyna Godyń, Natalia Szałaj, Paula Zaręba, Monika Głuch‐Lutwin, Barbara Mordyl, Dawid Panek, Anna Więckowska · 2024 · Molecules
96. Wnt/β-catenin Signaling in Central Nervous System Regeneration
    Dilek Nazli, Uğur Bora, Günes Özhan · 2024 · Advances in experimental medicine and biology
97. Pedunculoside alleviates cognitive deficits and neuronal cell apoptosis by activating the AMPK signaling cascade
    Liwei Li, Jinfeng Sun, Fan Chen, Xiong Li, Lingyu She, Hao Tang, Yuqing Zeng, Luyao Li, Wei Wang, Xia Zhao et al. · 2024 · Chinese Medicine
98. Synthesis and biological evaluation of novel pyrrolo[2,3-b]pyridine derivatives as potent GSK-3β inhibitors for treating Alzheimer's disease
    Qingqing Xun, Jing Zhang, Yan-Peng Li, Ying Li, Yuying Ma, Zhaobin Chen, Le-Ping Ding, Xiao-Long Shi · 2025 · European Journal of Medicinal Chemistry
99. RhoA/ROCK/GSK3β Signaling: A Keystone in Understanding Alzheimer’s Disease
    Milan M. Medd, Jayden E. Yon, Hongxin Dong · 2025 · Current Issues in Molecular Biology
100. Aging-dependent YAP1 reduction contributes to AD pathology by upregulating the Nr4a1-AKT/GSK-3β axis
     Ling Lei, Yilei Cheng, Anqi Yin, Jian-Min Han, Gang Wu, Fumin Yang, Qi Wang, Jian‐Zhi Wang, Rong Liu, Honglian Li et al. · 2025 · Translational Neurodegeneration